2025 France Ai-Based Clinical Trials Revenue Opportunities Report
Description
The 2025 France Ai-Based Clinical Trials Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the AI-based Clinical Trials by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest AI-based clinical trial companies actively participating in France include IQVIA, Dassault Systèmes (Medidata), Median Technologies, and Phesi. IQVIA, headquartered in the US but globally present, leads with advanced analytics and technology solutions elevating clinical research services, with a strong innovation focus in France. Dassault Systèmes, through its Medidata platform, provides AI-driven software that optimizes clinical trial design and management, serving the French market as a key global player. Median Technologies, based in Valbonne, France, specializes in AI-powered diagnostic tools, notably improving lung cancer screening and trial outcome measures through its eyonis LCS software.
Phesi, based in London with influence in France, utilizes AI for patient-centric data analytics, having developed a Trial Accelerator platform incorporating over 100 million patient data profiles to enhance trial planning and recruitment efficiency, thereby accelerating trial timelines and increasing accuracy in the French clinical trial landscape. Together, these companies drive AI adoption within France’s clinical trials by improving patient recruitment, trial design, diagnostics, and predictive modeling, playing a pivotal role in the rapidly evolving market projected to grow significantly by 2030.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the AI-based Clinical Trials by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest AI-based clinical trial companies actively participating in France include IQVIA, Dassault Systèmes (Medidata), Median Technologies, and Phesi. IQVIA, headquartered in the US but globally present, leads with advanced analytics and technology solutions elevating clinical research services, with a strong innovation focus in France. Dassault Systèmes, through its Medidata platform, provides AI-driven software that optimizes clinical trial design and management, serving the French market as a key global player. Median Technologies, based in Valbonne, France, specializes in AI-powered diagnostic tools, notably improving lung cancer screening and trial outcome measures through its eyonis LCS software.
Phesi, based in London with influence in France, utilizes AI for patient-centric data analytics, having developed a Trial Accelerator platform incorporating over 100 million patient data profiles to enhance trial planning and recruitment efficiency, thereby accelerating trial timelines and increasing accuracy in the French clinical trial landscape. Together, these companies drive AI adoption within France’s clinical trials by improving patient recruitment, trial design, diagnostics, and predictive modeling, playing a pivotal role in the rapidly evolving market projected to grow significantly by 2030.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
